bluebird bio, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BLUEAccesswire • 03/26/24
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 GuidanceBusiness Wire • 03/26/24
Lost Money on bluebird bio, Inc.(BLUE)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 03/25/24
bluebird bio, Inc. (BLUE) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 03/21/24
bluebird bio Being Investigated on Behalf of bluebird bio, Inc. Investors. Contact Levi & Korsinsky For DetailsAccesswire • 03/14/24
BLUE ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of bluebird bio, Inc. Shareholders Who Lost MoneyAccesswire • 03/13/24
ATTENTION bluebird bio, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 03/12/24
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene TherapyBusiness Wire • 03/11/24
bluebird bio, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - BLUEAccesswire • 03/11/24
Levi & Korsinsky Announces an Investigation on Behalf of bluebird bio, Inc. (BLUE) Shareholders Who May Have Been Affected by FraudAccesswire • 03/08/24
Lost Money on bluebird bio, Inc. (BLUE)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 03/07/24
Lost Money on bluebird bio, Inc.(BLUE)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire • 03/06/24
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial OutlookBusiness Wire • 01/08/24